Cargando…
Montelukast Use Decreases Cardiovascular Events in Asthmatics
Cysteinyl leukotrienes are proinflammatory mediators with a clinically established role in asthma and a human genetic and preclinical role in cardiovascular pathology. Given that cardiovascular disease has a critical inflammatory component, the aim of this work was to conduct an observational study...
Autores principales: | Hoxha, Malvina, Tedesco, Calogero C., Quaglin, Silvana, Malaj, Visar, Pustina, Linda, Capra, Valerie, Evans, Jilly F., Sala, Angelo, Rovati, G. Enrico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838535/ https://www.ncbi.nlm.nih.gov/pubmed/33519477 http://dx.doi.org/10.3389/fphar.2020.611561 |
Ejemplares similares
-
Montelukast Inhibits Platelet Activation Induced by Plasma From COVID-19 Patients
por: Camera, Marina, et al.
Publicado: (2022) -
Montelukast Improves Symptoms and Lung Function in Asthmatic Women Compared With Men
por: Esposito, Renata, et al.
Publicado: (2019) -
Folic Acid and Autism: A Systematic Review of the Current State of Knowledge
por: Hoxha, Bianka, et al.
Publicado: (2021) -
196 Effect of the Treatment With Montelukast in Asthmatic Patient
por: Aguila de la Coba, Roberto O., et al.
Publicado: (2012) -
A review on the role of fatty acids in colorectal cancer progression
por: Hoxha, Malvina, et al.
Publicado: (2022)